152 related articles for article (PubMed ID: 2536585)
1. Heterogeneity of intraductal carcinoma of the breast.
Patchefsky AS; Schwartz GF; Finkelstein SD; Prestipino A; Sohn SE; Singer JS; Feig SA
Cancer; 1989 Feb; 63(4):731-41. PubMed ID: 2536585
[TBL] [Abstract][Full Text] [Related]
2. Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment.
Schwartz GF; Patchefsky AS; Finklestein SD; Sohn SH; Prestipino A; Feig SA; Singer JS
Arch Surg; 1989 Jan; 124(1):29-32. PubMed ID: 2535928
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of ductal carcinoma in situ of the breast. 10- to 20-year follow-up.
Simpson T; Thirlby RC; Dail DH
Arch Surg; 1992 Apr; 127(4):468-72. PubMed ID: 1313671
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Parikh RR; Haffty BG; Lannin D; Moran MS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):7-13. PubMed ID: 20950955
[TBL] [Abstract][Full Text] [Related]
5. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
[TBL] [Abstract][Full Text] [Related]
6. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Wilkie C; White L; Dupont E; Cantor A; Cox CE
Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy.
Rosner D; Lane WW; Penetrante R
Cancer; 1991 Mar; 67(6):1498-503. PubMed ID: 1848153
[TBL] [Abstract][Full Text] [Related]
8. The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study.
Li Y; Zhang S; Wei X; Zhang J
Int J Surg; 2015 Jul; 19():91-4. PubMed ID: 26013173
[TBL] [Abstract][Full Text] [Related]
9. Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome.
Vieira CC; Mercado CL; Cangiarella JF; Moy L; Toth HK; Guth AA
Eur J Radiol; 2010 Jan; 73(1):102-7. PubMed ID: 19026501
[TBL] [Abstract][Full Text] [Related]
10. Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion.
Han S; Qiu F; Han Y; Xu Y; Yin J; Xing F; Bian X; He G
J Appl Clin Med Phys; 2021 Jan; 22(1):293-298. PubMed ID: 33332730
[TBL] [Abstract][Full Text] [Related]
11. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
[TBL] [Abstract][Full Text] [Related]
12. Multicentricity of non-palpable breast cancer.
Schwartz GF; Patchesfsky AS; Feig SA; Shaber GS; Schwartz AB
Cancer; 1980 Jun; 45(12):2913-6. PubMed ID: 6248183
[TBL] [Abstract][Full Text] [Related]
13. Intraductal carcinoma of the breast: follow-up after biopsy only.
Page DL; Dupont WD; Rogers LW; Landenberger M
Cancer; 1982 Feb; 49(4):751-8. PubMed ID: 6275978
[TBL] [Abstract][Full Text] [Related]
14. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
[TBL] [Abstract][Full Text] [Related]
15. Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis.
Zhang G; Li C; Tian G; Cheng X; Li Y; Ma L
Medicine (Baltimore); 2020 Dec; 99(52):e23593. PubMed ID: 33350734
[TBL] [Abstract][Full Text] [Related]
16. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease.
Schuh ME; Nemoto T; Penetrante RB; Rosner D; Dao TL
Arch Surg; 1986 Nov; 121(11):1303-7. PubMed ID: 3022676
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
18. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
[TBL] [Abstract][Full Text] [Related]
19. The prediction of lymph node metastasis in ductal carcinoma in situ with microinvasion by assessing lymphangiogenesis.
Lee SK; Cho EY; Kim WW; Kim SH; Hur SM; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH
J Surg Oncol; 2010 Sep; 102(3):225-9. PubMed ID: 20740579
[TBL] [Abstract][Full Text] [Related]
20. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures.
Lagios MD; Westdahl PR; Margolin FR; Rose MR
Cancer; 1982 Oct; 50(7):1309-14. PubMed ID: 6286091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
